CORTEX PHARMACEUTIC Analysis

CORTEX Stock Analysis Notes

About 15.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 1.31. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. CORTEX PHARMACEUTIC last dividend was issued on the 20th of May 2025. The entity had 2:1 split on the 9th of October 2014. PHX Minerals Inc. operates as a natural gas and oil mineral company in the United States. PHX Minerals Inc. was founded in 1926 and is based in Oklahoma City, Oklahoma. Phx Minerals operates under Oil Gas EP classification in the United States and is traded on New York Stock Exchange. It employs 20 people. To find out more about CORTEX PHARMACEUTIC contact Chad Stephens at (405) 948-1560 or learn more at https://phxmin.com.

CORTEX PHARMACEUTIC Investment Alerts

CORTEX PHARMACEUTIC Upcoming and Recent Events

CORTEX Market Capitalization

The company currently falls under 'Small-Cap' category with a total capitalization of 164.96 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate CORTEX PHARMACEUTIC's market, we take the total number of its shares issued and multiply it by CORTEX PHARMACEUTIC's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

CORTEX Profitablity

The company has Net Profit Margin of 0.19 %, which implies that it may need a different competitive strategy as even a very small decline in it revenue may erase profits and result in a net loss. This is way below average. In the same way, it shows Net Operating Margin of (0.04) %, which entails that for every $100 of revenue, it lost $0.04.

CORTEX PHARMACEUTIC Insider Trading Activities

CORTEX PHARMACEUTIC Predictive Daily Indicators

Stock analysis is the technique used by a trader or investor to examine and evaluate how CORTEX PHARMACEUTIC prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling CORTEX shares will generate the highest return on investment. We also built our delisted stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Delisted Stock such as CORTEX PHARMACEUTIC. By using and applying CORTEX Stock analysis, traders can create a robust methodology for identifying CORTEX entry and exit points for their positions.

Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.

If you are still planning to invest in CORTEX PHARMACEUTIC check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the CORTEX PHARMACEUTIC's history and understand the potential risks before investing.